KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Jun 07, 2019 $1.60 $1.70 $1.60 $1.63 7 987
Jun 06, 2019 $1.68 $1.69 $1.52 $1.52 1 329
Jun 05, 2019 $1.57 $1.67 $1.56 $1.60 8 120
Jun 04, 2019 $1.53 $1.63 $1.53 $1.63 17 373
Jun 03, 2019 $1.47 $1.52 $1.44 $1.52 5 368
May 31, 2019 $1.41 $1.47 $1.41 $1.47 7 009
May 30, 2019 $1.43 $1.45 $1.43 $1.45 14 586
May 29, 2019 $1.41 $1.42 $1.41 $1.41 17 974
May 28, 2019 $1.45 $1.46 $1.45 $1.46 1 727
May 24, 2019 $1.53 $1.53 $1.47 $1.47 1 099
May 23, 2019 $1.51 $1.51 $1.51 $1.51 422
May 22, 2019 $1.57 $1.57 $1.49 $1.49 1 688
May 21, 2019 $1.49 $1.56 $1.49 $1.50 3 710
May 20, 2019 $1.52 $1.59 $1.50 $1.53 3 792
May 17, 2019 $1.58 $1.60 $1.50 $1.60 1 634
May 16, 2019 $1.60 $1.67 $1.57 $1.61 1 725
May 15, 2019 $1.70 $1.70 $1.59 $1.69 10 724
May 14, 2019 $1.67 $1.70 $1.63 $1.70 20 196
May 13, 2019 $1.65 $1.68 $1.60 $1.63 12 165
May 10, 2019 $1.57 $1.67 $1.50 $1.67 11 298
May 09, 2019 $1.55 $1.60 $1.55 $1.57 8 156
May 08, 2019 $1.55 $1.62 $1.55 $1.56 5 120
May 07, 2019 $1.45 $1.62 $1.42 $1.55 25 737
May 06, 2019 $1.49 $1.61 $1.45 $1.47 23 837
May 03, 2019 $1.50 $1.59 $1.45 $1.59 22 051
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT